Abstract
Pancreatic cancer is one of the most lethal malignancies, as demonstrated by its 5-year survival rate of less than 10%. The poor response of pancreatic cancer to conventional therapeutics, especially against cancer stem cells (CSCs), is the primary obstacle to improving patient survival. Emerging evidence indicates that the long non-coding RNA (lncRNA) RP11-567G11.1 is up-regulated in pancreatic cancer tissues and that its expression is associated with poor prognosis. This study aimed to elucidate the mechanism by which RP11-567G11.1 influences survival in pancreatic cancer. We evaluated the expression of RP11-567G11.1 in pancreatic cancer tissues via in situ hybridization. We also constructed RP11-567G11.1 knockdown cell models and used CCK8 and flow cytometry to detect the function of this lncRNA. Western blotting and qPCR were used to detect the expression levels of factors related to RP11-567G11.1. The results illustrated that RP11-567G11.1 was significantly up-regulated in poorly differentiated pancreatic cancer tissues as compared to its expression in non-tumor tissues. Additionally, depletion of RP11-567G11.1 in pancreatic cancer cells inhibited proliferation and cell cycle progression, induced apoptosis, suppressed the ...Continue Reading
References
Feb 6, 2004·Development·Roi GazitNissim Ben-Arie
Oct 13, 2006·Development·Soline EstrachFiona M Watt
Nov 28, 2007·Annual Review of Pathology·Anirban Maitra, Ralph H Hruban
Mar 20, 2008·British Journal of Cancer·S MaedaS Takao
Mar 12, 2009·Cancer Research·Zhiwei WangFazlul H Sarkar
May 22, 2010·Stem Cells and Development·Zhuo YangRobert Chunhua Zhao
Jun 22, 2010·Cancer·Taiki MoriyamaMasao Tanaka
Oct 14, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Georgios KallifatidisIngrid Herr
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tilde EskildsenMoustapha Kassem
Jun 16, 2011·Breast Cancer Research : BCR·Naoko TakebeS Percy Ivy
Oct 11, 2011·Carcinogenesis·Sanjeev K SrivastavaAjay P Singh
Nov 1, 2011·PloS One·Nobuko TanoMuhammad Ashraf
Apr 11, 2012·Vascular Cell·Jian-Wei GuLucio Miele
May 8, 2013·International Journal of Cancer. Journal International Du Cancer·Marta VivesFrancesc Viñals
May 11, 2013·Cell Death & Disease·C HageI Herr
May 16, 2013·PloS One·Lulu FarhanaJoseph A Fontana
May 18, 2013·Cancer Science·Yusuke OharaNobuhiro Ohkohchi
Nov 28, 2013·PloS One·Kazuya ShimizuYuichi Hori
Jun 14, 2014·Advances in Biological Regulation·Timothy L Fitzgerald, James A McCubrey
Apr 9, 2015·Nature Reviews. Clinical Oncology·Naoko TakebeS Percy Ivy
Apr 16, 2015·Cellular Oncology (Dordrecht)·Chao YuChengyi Sun
Jul 3, 2015·Molecular Medicine Reports·Chao YuJianxin Jiang
Jul 18, 2015·Drug Design, Development and Therapy·Elena Gabriela Chiorean, Andrew L Coveler
Oct 9, 2015·Oncotarget·Yingxue WangRufu Chen
Citations
Sep 15, 2020·Cancer Biomarkers : Section a of Disease Markers·Tao JiXiaoming Zhang
Feb 18, 2021·Medicine·Anmei Wang, Junhua Lei
Mar 21, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Soudeh Ghafouri-FardMohammad Taheri
Apr 4, 2021·Cancers·Leila JahangiriSuzanne D Turner
May 27, 2021·Transcription·K T Ramya DeviSanjana Prakash Hemdev
Jul 3, 2021·International Journal of Molecular Sciences·Jorge Melendez-Zajgla, Vilma Maldonado
Jun 29, 2021·Frontiers in Oncology·Ammad Ahmad FarooqiWilliam C Cho